title: Effect of Astragulas membranaceus on natural killer cell activity and induction of alpha- and gamma-interferon in patients with Coxsackie B viral myocarditis.
abstract: The patients suffering from Coxsackie B viral myocarditis with depressed natural killer (NK) activity were treated with Astragulas membranaceus (AM) intramuscularly for 3-4 months. After the treatment, the NK activity was increased significantly from 11.5 +/- 11.9% before therapy to 44.9 +/- 15.0%. Another 6 patients of Coxsackie B viral myocarditis with depressed NK activity were treated with conventional therapy. The NK activity remained unchanged in 12.9 +/- 6%. The general condition and symptoms improved in all patients with AM therapy, while the titers of neutralizing antibody remained at the same level. Two days after AM treatment, the mean titers of alpha- and gamma-interferon (IFN) markedly increased in comparison with those before therapy and 3 weeks after AM therapy in 16 patients with Coxsackie B viral myocarditis, with left ventricular ejection fraction (LVEF) less than 65% and/or weak ventricular wall motion assayed by radionuclide angiocardiography. Whereas, in 12 patients treated with conventional therapy, there was no statistical difference among the results before and 2 days and 3 weeks after treatment. The results indicate that AM could partly regulate the lost of control of cellular immunity in patients with viral myocarditis.
authors.affiliation: Shanghai Institute of Cardiovascular Disease, Zhongshan Hospital, Shanghai Medical University.
authors.forename: Y Z
authors.initials: YZ
authors.lastname: Yang
authors.forename: P Y
authors.initials: PY
authors.lastname: Jin
authors.forename: Q
authors.initials: Q
authors.lastname: Gúo
authors.forename: Q D
authors.initials: QD
authors.lastname: Wang
authors.forename: Z S
authors.initials: ZS
authors.lastname: Li
authors.forename: Y C
authors.initials: YC
authors.lastname: Ye
authors.forename: Y F
authors.initials: YF
authors.lastname: Shan
authors.forename: H Y
authors.initials: HY
authors.lastname: Zhao
authors.forename: J R
authors.initials: JR
authors.lastname: Zhu
authors.forename: S Y
authors.initials: SY
authors.lastname: Pu
mesh_terms: D003384:Coxsackievirus Infections; D004365:Drugs, Chinese Herbal / Q000627:therapeutic use*; D029822:Enterovirus B, Human; D006801:Humans; D007370:Interferon Type I / Q000096:biosynthesis*; D007371:Interferon-gamma / Q000096:biosynthesis*; D007694:Killer Cells, Natural / Q000276:immunology*; D009205:Myocarditis / Q000188:drug therapy* / Q000209:etiology / Q000276:immunology
chemical_list: D004365:Drugs, Chinese Herbal; D007370:Interferon Type I; D007371:Interferon-gamma